Dr. Neil Binkley is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health, Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status and consideration of sarcopenia in fracture risk.
Jessica Buchanan: Teacher, Author, Humanitarian, Speaker, Survivor
On October 25, 2011, while on a routine field mission in Somalia, working as the Education Advisor for her non-governmental organization, Jessica was abducted at gunpoint and held for ransom by a group of Somali pirates for 93 days. Forced to live outdoors in deplorable conditions, starved, and terrorized by more than two dozen gangsters, Jessica’s health steadily deteriorated until, by order of President Obama, she was rescued by the elite SEAL Team VI on January 25, 2012.
Jessica’s ordeal is detailed in her New York Times bestselling book, Impossible Odds: The Kidnapping of Jessica Buchanan and Her Dramatic Rescue by SEAL Team Six.
Jessica has been named one of the ‘150 Women Who will Shake the World’ by Newsweek, and her story was the most highly viewed 60 Minutes episode to air, to date. Jessica is a highly sought-after inspirational speaker and her TEDx Pearl Street talk, ‘Change is Your Proof of Life’ has been the foundation for which she travels the world, inspiring audiences to access their resilience by identifying their own autonomy and choice in the middle of their own life changing event.
Jessica is the host of the popular conversational podcast, We Should Talk About That where she and her co-host attempt to unpack the uncomfortable topics that nobody is talking about, but definitely should. She also coaches aspiring speakers through her consultancy service: SPEAK UP. STAND OUT. Which is where she helps women find their voice, and gain the confidence to stand out by speaking up.
Jessica works as a family liaison volunteer for the non-profit organization, Hostage US, supporting former hostages and their families during captivity and eventual return and also continues to serve as a dedicated Ambassador for the Navy SEAL Foundation, which works to support families of fallen SEALs.
Jessica is currently working on her second book, From Deserts to Mountain Tops: A Traveler’s Guide to Surviving Survival– a memoir and self-help manual for those who have experienced hardship and are journeying from the desert of survival, back to the mountain top of finding themselves.
Dr. Susan Bukata is the chair of the Department of Orthopaedic Surgery at UC San Diego School of Medicine and UC San Diego Health. She was formerly at UCLA Health, where she served as orthopedic surgeon, professor and vice chair of orthopedics clinical operations, physician informaticist lead for musculoskeletal health providers and chief orthopedics liaison to community practice partners.
Dr. Angela M. Cheung is Professor of Medicine at University of Toronto (UT), the Founding Director of the UT Centre of Excellence in Skeletal Health Assessment (CESHA), the Founding Director of University Health Network (UHN) Osteoporosis Program and a Senior Scientist at Toronto General Hospital Research Institute. She is the current chair of the KY and Betty Ho Chair of Integrative Medicine at University of Toronto. She obtained her M.D. degree from Johns Hopkins University School of Medicine in 1988, and her PhD degree from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for 30 years. She currently holds a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. Twitter: @AngelaMCheung
Dr. Adi Cohen holds the position of Associate Professor of Medicine at CUMC in the Division of Endocrinology at Columbia University Irving Medical Center. Dr. Cohen is the Director of the Early-Onset Osteoporosis Center within the Metabolic Bone Diseases Program at CUIMC.
Dr. Cohen received her medical training at New York University School of Medicine and completed a fellowship in Endocrinology at Columbia University Medical Center, as well as a fellowship in Women’s Health at Duke University and the Durham VA Medical Center. She has obtained a Master’s Degree in Health Sciences (Clinical Research) through the Duke Clinical Research Institute. Dr. Cohen has published multiple articles on osteoporosis and bone health in premenopausal women. These articles appear in the Journal of Clinical Endocrinology and Metabolism, the Journal of Bone and Mineral Research, Maturitas, the Journal of Women’s Health, and Osteoporosis International.
Her current research focuses on osteoporosis in premenopausal women, pregnancy and lactation associated osteoporosis and the use of imaging tools for the noninvasive assessment of bone microstructure. Current studies investigate the pathogenesis of both idiopathic osteoporosis in premenopausal women (IOP) and pregnancy and lactation associated osteoporosis (PLO), as well as various treatment options for women with these conditions.
Dr. Felicia Cosman is a clinical scientist, osteoporosis specialist, Professor of Medicine at Columbia University and North American Co-Editor in Chief of Osteoporosis International. She received a BA from Cornell, MD from Stony Brook, and completed internship, residency and endocrinology fellowship at Columbia University College of Physicians and Surgeons.
Dr. Cosman has had many grants from NIH, DOD, MS Society, and industry and has published over 175 peer-reviewed papers and over 50 book chapters. She has been involved in the investigation of many pharmaceutical agents in the treatment of osteoporosis, but the main focus of her research has been in the use of anabolic medications and treatment sequencing. Dr. Cosman studied teriparatide’s actions using biochemical markers of bone turnover, bone density, central and peripheral computed tomography, finite element analysis and iliac crest bone biopsy. She has investigated cyclic, combination and sequential regimens of teriparatide and antiresorptive agents and evaluated teriparatide’s effect on bone formation in the human femoral neck. She has been a major contributor to pivotal studies of both romosozumab and abaloparatide. Dr. Cosman is a leader in concepts regarding early use of anabolic agents in high-risk patients, optimal treatment sequences, longterm treatment strategies and therapeutic goals for osteoporosis management.
Dr. Cosman has been a member of multiple ASBMR and NOF task forces and committees and was Clinical Director for the NOF for 20 years and Chairman of the Clinician’s Guide Committee in 2013-2014. She has been an NIH grant reviewer, associate editor for several journals, and review editor for OI for 15 years. She was an Associate Editor for the fifth edition of Marcus and Feldman’s Osteoporosis 2020, and has been Co-Editor-in-Chief of Osteoporosis International since 2016.
She is an AOA Medical Society honoree, has received NOF’s Generations Award, ASBMR Best Abstract award on two occasions and was a Castle-Connolly Top Doctor for 20 consecutive years. She received the ACE Distinction in Endocrinology Award in 2019 and was designated the ASBMR Frederic C. Bartter Award winner in September 2020.
Dr. Kristi Tough DeSapri is a board certified women’s health specialty internist, and clinical assistant professor of Ob/GYN and Internal Medicine at the Feinberg School of Medicine at Northwestern University. She is the director of the Northwestern Women’s Bone Health program. Her career started in Ob/GYN, followed residency in internal medicine and then a women’s health fellowship at the Cleveland Clinic. She has an exclusive consult practice treating midlife women’s issues such as perimenopause, menopause, osteoporosis/bone health, and sexual medicine. In addition, she lectures nationally and has published on both contraception and bone health. With her expertise as a NAMS (North American Menopause Society) certified practitioner and ISCD certified clinical densitometrist (CCD) she is active with NOF and ASBMR. Recognizing that osteoporosis and menopause management are both underdiagnosed and undertreated, she takes responsibility for treating midlife women.
She is an AOA Medical Society honoree, has received NOF’s Generations Award, ASBMR Best Abstract award on two occasions and was a Castle-Connolly Top Doctor for 20 consecutive years. She received the ACE Distinction in Endocrinology Award in 2019 and was designated the ASBMR Frederic C. Bartter Award winner in September 2020.
Dr. Kristi Tough DeSapri is a board certified women’s health specialty internist, and clinical assistant professor of Ob/GYN and Internal Medicine at the Feinberg School of Medicine at Northwestern University. She is the director of the Northwestern Women’s Bone Health program. Her career started in Ob/GYN, followed residency in internal medicine and then a women’s health fellowship at the Cleveland Clinic. She has an exclusive consult practice treating midlife women’s issues such as perimenopause, menopause, osteoporosis/bone health, and sexual medicine. In addition, she lectures nationally and has published on both contraception and bone health. With her expertise as a NAMS (North American Menopause Society) certified practitioner and ISCD certified clinical densitometrist (CCD) she is active with NOF and ASBMR. Recognizing that osteoporosis and menopause management are both underdiagnosed and undertreated, she takes responsibility for treating midlife women.
Freda Hannafon is a family nurse practitioner in Rochester, NY. She has practiced at the University of Rochester and UCLA. Ms. Hannafon is now at Rochester Regional Health and specializes in endocrinology.
Dr. Steven Harris is a board-certified internist and endocrinologist with a subspecialty focus on osteoporosis, metabolic bone disease and disorders of mineral metabolism. He received his medical degree from the University of California, San Francisco, and completed a residency and chief residency in Internal Medicine at the same institution. He completed a clinical and research fellowship in Endocrinology and Metabolism at Massachusetts General Hospital in Boston. He then returned to the University of California, San Francisco, where he is a Clinical Professor of Medicine. Dr. Harris has spent many years working on a variety of clinical research projects to examine the effects of nutrition, calcium supplements, vitamin D, hormone therapy, bisphosphonates, calcitonin, PTH and SERMs upon the prevention and treatment of osteoporosis. Dr. Harris maintains an active consultative practice in metabolic bone disease, but is also engaged in a wide variety of educational initiatives related to osteoporosis.
Mr. Lawrence Jankowski is the chief DXA technologist and a research coordinator at the Illinois Bone and Joint Institute, a multi-specialty 100 plus physician practice serving the greater Chicago area. He is chair of the ISCD Facility Accreditation Program, ISCD board member, and technical faculty for the ISCD Quality Bone Densitometry and ISCD/IOF Osteoporosis Essentials courses.
In addition, he serves as a volunteer moderator for the National Osteoporosis Foundation’s osteoporosis support group, and has co-authored several ISCD official position manuscripts, and served on several Position Development Conference expert panels.
Clayton LaBaume graduated from the Texas Tech physician assistant program in 2008. He initially worked in internal medicine in the hospital and critical care setting. He later went to work in neurosurgery and orthopedic spine surgery. Through all of these different care settings, he helped take care of patients with consequences of osteoporosis. Experiencing the gap in osteoporosis care, he developed a special interest in bone health and fracture prevention and created a post fracture program to ensure that patients would be treated after sustaining a fracture. He moved into his current role at Mercy Orthopedics in Durango in 2016 to grow the FLS and bone health program. Clayton is the Chief Information Officer for RPJ FLS, which is a post fracture osteoporosis program implementation consulting company. He takes pride in troubleshooting and improving processes to help post fracture osteoporosis programs become successful.
His philosophy of care is to help people live longer, independent, high quality lives through fracture prevention and preservation of longevity/functional capacity.
Clayton and his wife have lived in Durango since 2010 and they enjoy the outdoor life that the area provides. His hobbies include: mountain biking, running, skiing, cooking, travel, and oil painting.
Dr. Janet Y. Lee is an Assistant Professor of Pediatrics and of Medicine in the Divisions of Pediatric Endocrinology and of Endocrinology & Metabolism at the University of California, San Francisco. A pediatric and adult endocrinologist, Dr. Lee has focused clinical interests in metabolic bone disease and provides gender-affirming medical therapy to transgender and gender diverse youth and adults, with strong interests in increasing access to care as well as conducting and supporting high-quality research in transgender medicine. Dr. Leeís primary research program focuses on understanding the skeletal effects of gender-affirming medical therapy in transgender and gender diverse youth with the goal of optimizing current treatment protocols.
E. Michael Lewiecki, MD, FACP, FACE, FASBMR, CCD, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO (Extension for Community Healthcare Outcomes) at University of New Mexico Health Sciences Center in Albuquerque, NM. He is a consultant in osteoporosis and metabolic bone diseases, supervisor of bone densitometry at his center, and an educator with a special interest in the management of osteoporosis and metabolic bone diseases. He is principal investigator for the center’s osteoporosis clinical trials and author of over 300 scientific publications on osteoporosis and assessment of skeletal health. Dr. Lewiecki is a board member and telehealth advisor for the National Osteoporosis Foundation and past-president of the International Society for Clinical Densitometry. He is founding president of the Osteoporosis Foundation of New Mexico and program director of its flagship activity, the annual Santa Fe Bone Symposium.
Dr. Michael McClung is an endocrinologist and founding director of the Oregon Osteoporosis Center in Portland. For more than 40 years, he has cared for patients with osteoporosis, participated in pivotal clinical trials and taught primary care physicians about managing patients with osteoporosis.
Dr. Michael McClung is the founding director of the Oregon Osteoporosis Center, an Adjunct Professor of Medicine at the Oregon Health & Science University and Professorial Fellow at the Mary MacKillop Institute for Health Research, Australian Catholic University in Melbourne,Australia. He graduated from Rice University in Houston and from the University of Texas Southwestern Medical School in Dallas. After his training in Internal Medicine at Parkland Hospital in Dallas, he completed a fellowship in Endocrinology at the National Institute of Health in Bethesda, Maryland. Since then, he has held several academic appointments and has been actively involved in the training of young physicians in Oregon and at sites around the world
At the Oregon Osteoporosis Center, Dr. McClung had an active clinical practice, took part in multiple educational initiatives and was an investigator in many clinical trials evaluating the effects of therapeutic agents for osteoporosis.
Dr. Paul Miller is Founder and Medical Director at the Miller Bone Center, part of the Colorado Center for Bone Health. He is also a Distinguished Clinical Professor of Medicine at the University of Colorado, Health Sciences Center. He is Board Certified in both Internal Medicine and Nephrology. He is an internationally recognized physician specializing in metabolic bone disease and is widely considered a leading authority on bone biology, prevention, and treatment of metabolic bone disorders, including osteoporosis.
Dr. Millerís research focuses on the treatment of osteoporosis in postmenopausal women, and he is the Principal Investigator in a number of clinical trials evaluating the safety and efficacy of current and potential therapies. He is author and co-author of over 300 peer-reviewed publications, and 50 textbook chapters, atlases, and books.
Dr. Miller is the founding President of The International Society for Clinical Densitometry and Emeritus Editor-in-Chief of the Journal of Clinical Densitometry. He serves on the editorial boards of Osteoporosis International, Calcified Tissues International, Journal of Womenís Heath, and the National Osteoporosis Foundationís Osteoporosis: Clinical Updates Newsletter, Up-to-Date and the advisory board of Ostego, LLC. He is a reviewer for the Annals of Internal Medicine, Calcified Tissue International, Journal of Bone and Mineral Research, The New England Journal of Medicine and JAMA.
Dr. Miller received an Honorary Doctor of Science from his undergraduate alma mater, Gettysburg College, and his medical degree from The George Washington University School of Medicine in Washington, DC, which also awarded him in 2103 The Distinguished Alumni Award. He served his internship, residency, and chief residency at the University of Rochester School of Medicine, Strong Memorial Hospital, Rochester, NY, and completed clinical and research fellowships in renal diseases at the University of Colorado Medical Center in Denver. He has remained in Denver since 1974, involved in renal medicine and metabolic bone disease from 1977 to 1994, and then established the Colorado Center for Bone Researchóa clinical and research facility caring for a broad spectrum of metabolic bone diseases. Dr., Miller is Principal Investigator or Co-Investigator in FDA-approved therapies for osteoporosis, Pagetís disease, renal bone disease, osteogenesis imperfecta, steroid-induced osteoporosis, hypophosphatasia, and other rare bone diseases. He is board certified in both internal medicine and nephrology.
Dr. Susan Morgan is the Medical Director of the University of Alabama at Birmingham Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry (DXA) Service. The UAB DXA service is accredited by the International Society for Clinical Densitometry. She received degrees in Food and Nutrition and Dietetics and Food and Nutrition and Related Sciences at Iowa State University and completed medical school and an internal medicine internship and residency at the University of Iowa. She completed a Clinical Nutrition fellowship and a master’s degree in Clinical Nutrition at the University of Alabama at Birmingham (UAB). She currently is a Professor of Medicine and Nutrition Sciences in the Division of Clinical Immunology and Rheumatology at UAB. Dr. Morgan’s research interests are in the areas of folate and methotrexate metabolism in rheumatoid arthritis and bone densitometry and she participates in osteoporosis and DXA clinical trials in the UAB Osteoporosis Clinic. Dr. Morgan is a past President of the International Society for Clinical Densitometry and past chair of the Education Council. She is a current instructor of Osteoporosis Essentials and VFA courses and is a member of the Accreditation committee and the Facility Membership Committee.
Kavita Patel, PT, DPT CCI is a clinical specialist physical therapist at Kessler Rehabilitation Center (KRC) in Clifton where she works with all populations utilizing various types of interventions and treatment approaches including McKenzie, Maitland, muscle energy techniques, IASTM, cupping and taping. She is also BoneFit™ trained through the National Osteoporosis Foundation (NOF). Kavita has been a practicing clinician for more than 25 years.
Dr. Arthur C. Santora II is a clinical endocrinologist who spent most of his professional life in clinical research, including almost 28 years in the clinical research team at Merck Research Labs in New Jersey, involved in the clinical development of alendronate (Fosamax) for the treatment of osteoporosis. He received his M.D. and Ph.D. in biochemistry and Internal Medicine training at Emory University in Atlanta. Following a clinical fellowship in endocrinology at NIH in Bethesda, he served for 2 years as a Medical Officer at the US FDA. After 3 years at Wayne State University Medical School in Detroit, he joined Merck in 1989. While at Merck he participated in most of Merck’s phase 2, 3 and post marketing studies of alendronate in the treatment of osteoporosis. He led the once-weekly alendronate and alendronate/Vitamin D3combination product development and was a member of the alendronate pharmacovigilance team. Since retiring from Merck in April 2017 had has been a clinical pharmaceutical research consultant and is currently Chief Medical Officer of Entera Bio Ltd. He continues to participate in patient care and education as a clinical associate professor at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey.
Dr. Anne Schafer is Associate Professor of Medicine and of Epidemiology & Biostatistics at the University of California, San Francisco and Chief of Endocrinology and Metabolism at the San Francisco VA Health Care System. Her research focus is osteoporosis and bone metabolism. One of her research emphases is osteoporosis treatment and the assessment of response to osteoporosis therapy. She also studies the relationships between bone, fat, and glucose metabolism, including the effects of obesity and diabetes on bone, and the skeletal effects of bariatric surgery. Dr. Schafer’s research has been funded by the NIH (National Institute of Diabetes and Digestive and Kidney Diseases), the US Department of Veterans Affairs, and the American Society for Bone and Mineral Research.
Andrea J. Singer, MD is a member of the Departments of Medicine and Obstetrics and Gynecology at Medstar Georgetown University Hospital and serves as Director of Women’s Primary Care. She is a Certified Clinical Densitometrist and is the Director of the Bone Densitometry Program within the Department of Obstetrics and Gynecology. She is also the Medical Director of the Georgetown VIP Health Check Program. She holds a faculty appointment as an Associate Professor of Medicine and Obstetrics and Gynecology at Georgetown University Medical Center (GUMC). Dr. Singer is also the Clinical Director of the National Osteoporosis Foundation.
Dr. Singer is a national leader in primary care and women’s health and has published and lectured extensively on such topics as osteoporosis, the primary care of women, midlife women’s health, obesity and weight management, female sexuality and sexual dysfunction, fibromyalgia, and depression in women. She is active in the education of both medical students and residents at GUMC as well as in numerous regional and national continuing medical education programs. She is the director of the Reproduction Module and the Human Sexuality Course at GUMC.
Dr. Singer graduated magna cum laude from Brown University with an undergraduate degree in Human Biology, received her medical degree from the Albert Einstein College of Medicine and is an Alpha Omega Alpha, National Medical Honor Society inductee. She completed her internship and residency in Internal Medicine at GUMC, served as chief medical resident, and joined their faculty in 1994.
Heidi Skolnik, M.S., C.D.N., FACSM: Considered a thought leader in nutrition, Heidi has influenced millions through her media work, writing and thriving consulting business. Her company, Nutrition Conditioning, oversees the Sports Nutrition program at The Juilliard School and the School of American Ballet and Skolnik has consulted with numerous Broadway Shows, including Hamilton, Am American in Paris and Billy Elliot, as well as with movie and TV actors. She has been a part of The Women’s Sports Medicine Center at Hospital for Special Surgery for over 20 years. Skolnik worked with the The NY Knicks Basketball Team (7 years), NY Giants Football team (18 years), the NY Mets Baseball organization (15 years) and has worked with the NHL, MLS, WNBA, Olympic competitors, professional cyclists, marathoners, and collegiate athletes. Heidi sat on the board of The National Osteoporosis Foundation for 10 years and is an advisor to Eat This Not That Bookazine.
Heidi is author of The Athlete Triad Playbook/Relative Energy Deficiency in Sport (https://athletetriadplaybook.com), Grill Yourself Skinny and is co-author of Nutrient Timing for Peak Performance: The right food, the right time, the right results and The Reverse Diet: Lose Weight By Eating Dinner for Breakfast and Breakfast for Dinner. An expert resource for national media, Heidi has appeared on; Live! With Kelly and Michael; So You Think You Can Dance; The Meredith Vieira Show; The Today Show, Good Morning America, The Early Show: Dr. Oz; CNN American Morning and Headline News, Primetime, 20/20, Extra as well as the Food Network and is often referenced in both on-line and print media.
Heidi has earned two Masters degrees (one in exercise physiology, the other in human nutrition) and is a New York State Certified Nutritionist. Skolnik is a Fellow with the American College of Sports Medicine(ACSM) and is also ACSM certified as a Health Fitness Instructor. Heidi began her career in corporate fitness and wellness at Morgan Stanley for the Sports Training Institute.
As a realist, Heidi believes M&M’s can fit into a healthy eating style along with red peppers, red meat, broccoli, and fresh fruit and recognizes that fitness has to be a regular part of the daily routine to maintain and achieve her fitness goals – which vary based on what is going on in the rest of her life. Healthy eating and exercise change and evolve as we do.
Irinel Stanciu, MD, FACE, CCD is a board-certified endocrinologist who specializes in osteoporosis, hyperparathyroidism and metabolic bone disorders. Dr. Stanciu has training in general surgery, internal medicine and endocrinology. She has worked as both an internal medicine and endocrine physician giving her a broad spectrum of experience with endocrine disorders and general health. Dr. Stanciu joins the Colorado Center for Bone Research at Panorama from St. Lukeís Clinic Idaho Endocrinology in Boise Idaho where she was considered the authority on metabolic bone and endocrine disorders.
Dr. Stanciu was born in Bucharest, Romania to a father who was a vet and a mother who was a nurse. Due to this early exposure to medicine and its ability to change peopleís lives, Dr. Stanciu developed a passion for medicine and a dream of being a doctor. Despite the extremely challenging road to becoming a physician in Romania and her parentsí advice, she pursued medical school. After passing her exams to enter University, Dr. Stanciu attended medical school at Carol Davila University in Bucharest, Romania. She continued her training with an internship in general surgery at Emergency Clinical Hospital followed by a general medicine residency at Fundeni Clinical Hospital both in Bucharest, Romania. Toward the end of her medical school, in 1989, the Romanian Revolution began leaving Dr. Stanciu trapped for three days in the hospital caring for patients because it was too dangerous to leave.
Dr. Stanciu moved to the United States in 1997 to complete an internal medicine residency at Cook County Hospital in Chicago. Following residency, she chose to complete an endocrine fellowship at Loyola University in Maywood, Illinois. She received her board certification in endocrinology and metabolism in 2008. Prior to joining Panorama, Dr. Stanciu had been practicing at St. Lukeís Clinic ñ Idaho Endocrinology, where she most recently spearheaded the St. Lukeís Osteoporosis and Fracture Liaison Service to help promote the treatment, prevention and follow-up of osteoporosis care.
Dr. Stanciu is excited to further the research in metabolic bone. She treats the bone as an intricate universe and treats every case individually and uniquely, stating that, ìwe may study disorders but in the clinic, I have in front of me a person with a dysfunction that needs restorationî. Her favorite part about osteoporosis and metabolic bone disorders is that it is challenging and requires a lot of thinking as well as finding the cause of the fracture. She likes to understand the causes over treating the symptoms that patients present. Her goal is to make every patient comfortable and encourage them to be an active participant in their healing. Dr. Stanciu looks at her practice as patient oriented and wants to be cost meaningful in her treatment and diagnosis. She does not just run tests just because they are available. ìEvery test I order has to help me diagnose appropriately and treat my patient.î Dr. Stanciu says.
Dr. Stanciu is excited to fulfill the dream that started in Romania and loves that she is able to do that at the Colorado Center for Bone Research. She had heard of the Colorado Center for Bone Research at several conferences over the years and jumped at the opportunity to work as one of its physicians. She is looking forward to the challenges that a true metabolic practice presents and the opportunity that is presented by partnering with Panorama. ìThe concept of orthopedic collaboration is an overdue model. The partnership will help patients both in improving orthopedic outcomes and discovering and preventing metabolic bone disease early on,î said Dr. Stanciu. ìOther communities should embrace it,î she adds.
When she is not working, Dr. Stanciu enjoys the beautiful weather and mountains of Colorado, where she can be found hiking and camping in the summer and skiing in the winter. She has two daughters and one granddaughter.
Dr. Emily Margaret Stein is Director of Research for the Metabolic Bone Service at The Hospital for Special Surgery. She is also an Associate Professor of Medicine at Weill Cornell Medical College. Dr. Stein is an Endocrinologist who specializes in osteoporosis and metabolic bone disease. Her research, supported by the National Institutes of Health, American Society of Bone and Mineral Research, as well as private foundations has focused on investigating the quality of bone in patients with osteoporotic fractures, and the skeletal effects of glucocorticoids, transplantation osteoporosis and bariatric surgery. She has also studied abnormalities of vitamin D metabolism in different populations.